What is the level of liabilities of Accuray this year?
Accuray has a debt balance of 423.54 M USD this year.
Accuray Liabilities 2024
Accuray Liabilities
423.54 M USD
Ticker
ARAY
ISIN
US0043971052
WKN
A0MKWM
In 2024, Accuray's total liabilities amounted to 423.54 M USD, a 0.92% difference from the 419.7 M USD total liabilities in the previous year.
Accuray Aktienanalyse
What does Accuray do?
Accuray Inc is a company that was founded in 1990 and is headquartered in Sunnyvale, California. It is a global leader in providing precision solutions for the radiation treatment of cancer and other medical conditions. The company aims to develop revolutionary technologies that offer doctors and patients new treatment options for cancer and other diseases. History: Accuray was founded as a start-up company by a group of scientists who believed that cancer treatment was a crucial problem, with a lack of precision and control compromising the effectiveness of treatment. Therefore, they decided to develop a solution focused on precise, non-invasive radiation therapy. Since then, Accuray has continuously developed and introduced innovative technologies to enable better treatment for patients. Business model: Accuray's business model focuses on the development, sale, and service of radiation therapy products and solutions. The company provides global clinical support to ensure that customers receive the best possible application of Accuray technologies. Accuray primarily generates its revenues through the sale of radiation therapy systems and services. The company has over 800 employees worldwide and operates manufacturing locations in the US and China. Products and solutions: Accuray offers a wide range of products and solutions for clinical radiation therapy. These include the TomoTherapy systems, CyberKnife systems, and Radixact systems. The TomoTherapy systems have been specifically designed for precise and patient-specific radiation therapy applications. The technology enables precise dosage of radiation to tumor cells, protecting the surrounding healthy tissues. The CyberKnife system is used for the treatment of tumors that are difficult to access, such as those in the brain or spine. The robotic technology and precise radiation dosage enhance the effectiveness of treatment. With the Radixact system, Accuray offers a system that provides the latest generation of radiation therapy. The system delivers extremely precise dosages to the tumor while maximizing the preservation of surrounding tissues. Divisions: Accuray is divided into three business segments: Oncology Systems, Radiation Therapy Services, and Research Solutions. - Oncology Systems: Accuray offers the aforementioned TomoTherapy, CyberKnife, and Radixact systems, providing customers with the latest technology to treat various types of cancer. - Radiation Therapy Services: Accuray also provides a wide range of service and support offerings for its customers. These services include training, maintenance, technician support, and customer support. - Research Solutions: Accuray's research division provides academic institutions and research laboratories with access to a variety of technologies and solutions for radiation therapy and cancer research. Conclusion: Accuray has tirelessly worked to develop innovative technologies for radiation therapy, enabling better treatment and quality of life for patients. The company has made significant progress in recent years and now offers a wide range of products and solutions to its customers. Accuray has established itself as a global leader in radiation therapy and continues its success story with continuous research and innovation. Answer: Accuray Inc is a company that specializes in providing precision solutions for radiation treatment of cancer and other medical conditions. It was founded in 1990 and is headquartered in Sunnyvale, California. The company aims to develop innovative technologies that offer patients and doctors new treatment possibilities. Accuray has three divisions: Oncology Systems, Radiation Therapy Services, and Research Solutions. Their products include TomoTherapy, CyberKnife, and Radixact systems. Accuray is a leading global provider of radiation therapy solutions and continues to make advancements in research and innovation. Accuray ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Accuray's Liabilities
Accuray's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Accuray's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Accuray's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Accuray's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Accuray’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Accuray stock
What were the liabilities of Accuray compared to the previous year?
The liabilities of Accuray have increased by 0.92% increased compared to the previous year.
What are the consequences of high debt for investors of Accuray?
High liabilities can pose a risk for investors of Accuray, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Accuray?
Low liabilities mean that Accuray has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Accuray affect the company?
An increase in liabilities of Accuray can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Accuray affect the company?
A decrease in the liabilities of Accuray can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Accuray?
Some factors that can influence the liabilities of Accuray include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Accuray so important for investors?
The liabilities of Accuray are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Accuray take to modify the liabilities?
To change its liabilities, Accuray can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Accuray pay?
Over the past 12 months, Accuray paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accuray is expected to pay a dividend of 0 USD.
What is the dividend yield of Accuray?
The current dividend yield of Accuray is .
When does Accuray pay dividends?
Accuray pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Accuray?
Accuray paid dividends every year for the past 0 years.
What is the dividend of Accuray?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Accuray located?
Accuray is assigned to the 'Health' sector.
Wann musste ich die Aktien von Accuray kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Accuray from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Accuray pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Accuray in the year 2023?
In the year 2023, Accuray distributed 0 USD as dividends.
In which currency does Accuray pay out the dividend?
The dividends of Accuray are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Accuray stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Accuray
Our stock analysis for Accuray Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accuray Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
